Venous Thromboembolism and Pulmonary Embolism: The forgotten High Risk Disease

Professor DA Fitzmaurice
Department of Primary Care & General Practice
University of Birmingham
United Kingdom

Should HDL and TGs be targeted in diabetes?

Dr. Peter Lansberg
Amsterdam
The Netherlands

What should glycaemic and blood pressure targets be?

Dr Neil Munro
Associate Specialist in Diabetes, Chelsea and Westminster Hospital
General Practitioner,Surrey

Co-morbidities in Heart Failure and improving Concordance with Treatments

Prof. Arno Hoes
Utrecht
The Netherlands

 

Syncope

What are the headline recommendations?
 

Do Cardiac Biomarkers or Tests add value to CVD Risk Prediction?

Prof. Arno Hoes
Utrecht
The Netherlands

Should we treat Lifetime risk in CVD Prevention?

Dr. Peter Lansberg
Amsterdam
The Netherlands

What’s new in diagnosis: is there a clear diagnostic pathway?

Prof. Frans Rutten, MD, PhD
Julius Center for Health Sciences and Primary Care
Utrecht, The Netherlands

CVD in Europe: How do I assess risk and what's new?

Prof. Terje Pedersen
Oslo
Norway

Transient Ischaemic Attacks: How to diagnose and what to do?

Prof. Richard Mcmanus
Birmingham
United Kingdom

What's New in Hypertension?

Dr. Thierry Christiaens,
Gent
Belgium